More articles from Article

You have access
Cytochrome P450 Transcriptional Regulation by TSPYLs: Identification of Novel Upstream Transcription Factors
Suganti Shivaram, Huanyao Gao, Sisi Qin, Duan Liu, Richard M. Weinshilboum and Liewei Wang

Drug Metabolism and Disposition September 24, 2022, DMD-AR-2022-000945; DOI: https://doi.org/10.1124/dmd.122.000945
You have access
Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined With EnteroTracker for Biliary Sampling
Bo Wen, Ying Zhang, Graeme C. Young, David Kenworthy, Adrian Pereira, Jill Pirhalla, Janine Doyle, Bethany Jordon, Joyce Zhan and Mark Johnson

Drug Metabolism and Disposition September 24, 2022, DMD-AR-2022-000955; DOI: https://doi.org/10.1124/dmd.122.000955
You have access
Gut microbiome-wide search for bacterial azoreductases reveals potentially uncharacterized azoreductases encoded in the human gut microbiome
Domenick J. Braccia, Glory Minabou Ndjite, Ashley Weiss, Sophia Levy, Stephenie Abeysinghe, Xiaofang Jiang, Mihai Pop and Brantley Hall

Drug Metabolism and Disposition September 18, 2022, DMD-AR-2022-000898; DOI: https://doi.org/10.1124/dmd.122.000898
You have access
Sexual Dimorphism in the Expression of Cytochrome P450 Enzymes in Rat Heart, Liver, Kidney, Lung, Brain, and Small Intestine
Samar H. Gerges and Ayman O.S. El-Kadi

Drug Metabolism and Disposition September 18, 2022, DMD-AR-2022-000915; DOI: https://doi.org/10.1124/dmd.122.000915
You have access
Inhibition of Cytochrome P450 2J2-Mediated Metabolism of Rivaroxaban and Arachidonic Acid by Ibrutinib and Osimertinib
Ziteng Wang and Eric Chun Yong Chan

Drug Metabolism and Disposition October 2022, 50 (10) 1332-1341; DOI: https://doi.org/10.1124/dmd.122.000928
You have access
Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic Acid as a Urinary Biomarker of CYP2D6 Activity
Andrew C Behrle, Justin Douglas, J. Steven Leeder and Leon van Haandel

Drug Metabolism and Disposition October 2022, 50 (10) 1342-1351; DOI: https://doi.org/10.1124/dmd.122.000957
You have access
Mesenchymal Stem Cell Fates in Murine Acute Liver Injury and Chronic Liver Fibrosis Induced by Carbon Tetrachloride
Chenhui Ma, Li Han, Jiajun Wu, Feng Tang, Qiangqiang Deng, Ting He, Zhitao Wu, Chen Ma, Wei Huang, Ruimin Huang and Guoyu Pan

Drug Metabolism and Disposition October 2022, 50 (10) 1352-1360; DOI: https://doi.org/10.1124/dmd.122.000958
You have access
Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, a First-In-Class Ketohexokinase Inhibitor for Metabolic Disorders and Nonalcoholic Fatty Liver Disease
Yan Weng, Kari R. Fonseca, Yi-an Bi, Sumathy Mathialagan, Keith Riccardi, Elaine Tseng, Andrew J. Bessire, Mathew A. Cerny, David A. Tess, A. David Rodrigues, Amit S. Kalgutkar, John Litchfield, Li Di and Manthena V. S. Varma

Drug Metabolism and Disposition September 2022, 50 (9) 1312-1321; DOI: https://doi.org/10.1124/dmd.122.000953
You have access
Pharmacokinetic Modeling of Warfarin ІI – Model-Based Analysis of Warfarin Metabolites after Warfarin Administered Either Alone or Together with Fluconazole or Rifampin
Shen Cheng, Darcy R. Flora, Allan E. Rettie, Richard C. Brundage and Timothy S. Tracy

Drug Metabolism and Disposition September 2022, 50 (9) 1302-1311; DOI: https://doi.org/10.1124/dmd.122.000877
You have access
Pharmacokinetic Modeling of Warfarin І – Model-Based Analysis of Warfarin Enantiomers with a Target Mediated Drug Disposition Model Reveals CYP2C9 Genotype-Dependent Drug-Drug Interactions of S-Warfarin
Shen Cheng, Darcy R. Flora, Allan E. Rettie, Richard C. Brundage and Timothy S. Tracy

Drug Metabolism and Disposition September 2022, 50 (9) 1287-1301; DOI: https://doi.org/10.1124/dmd.122.000876

Main menu

User menu

Search

More articles from Article

Pages

Navigate

More Information

ASPET's Other Journals